NCT07331857 2026-01-12
Digma System First in Human (FIH) Study
Digma Medical Ltd.
Phase NA Not yet recruiting
Clinical Trials
28 trialsNCT05778851 2025-10-30
ASBE
Lucid Diagnostics, Inc.
Phase NA Completed
NCT06030180 2025-06-27
PR-0410
PAVmed Inc.
Phase NA Completed
NCT02514525 2025-01-13
ColdPlayIII
Pentax Medical
Phase NA Active not recruiting
NCT03311451 2025-01-13
C2 CryoBalloonâ„¢ 180 Ablation System Dose De-escalation Study.
Pentax Medical
Phase NA Enrolling by invitation
NCT05200325 2023-12-04
Clinical Utility Evidence for TissueCypher®
Qure Healthcare, LLC
Phase NA Completed
NCT05846971 2023-05-06
Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus
Capsulomics, Inc.
Phase NA Unknown
NCT04293458 2023-01-25
ESOGUARDBE1
PAVmed Inc.
Phase NA Completed
NCT04295811 2023-01-25
ESOGUARDBE2
PAVmed Inc.
Phase NA Unknown
NCT01293448 2022-04-28
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
Pentax Medical
Phase NA Completed
NCT02249975 2022-04-28
Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium
Pentax Medical
Phase NA Completed
NCT03097666 2022-04-22
Evaluation of Safety and Dose Response Using C2 CryoBalloonâ„¢ Swipe Ablation System for Barrett's Esophagus
Pentax Medical
Phase NA Completed
NCT03621319 2021-07-06
BURN
Erbe Elektromedizin GmbH
Phase NA Terminated
NCT02597712 2021-04-12
YF476 in Barrett's Esophagus
Trio Medicines Ltd.
Phase 2 Completed
NCT02864043 2020-03-04
DDP
NinePoint Medical
Phase NA Unknown
NCT02395471 2019-07-30
CASEII
Medtronic - MITG
Phase NA Completed
NCT00282672 2017-11-06
Ablation of Intestinal Metaplasia Containing Dysplasia
Medtronic - MITG
Phase NA Completed
NCT02162758 2017-05-11
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Takeda
Phase 2 Terminated
NCT00489268 2017-03-13
AIM
Medtronic - MITG
Phase NA Completed
NCT00795184 2016-05-03
DONTBIOPCE
Mauna Kea Technologies
Phase NA Completed
NCT01845454 2016-04-29
DOSE
CSA Medical, Inc.
Phase NA Terminated
NCT01032044 2016-04-22
CLEAN-MARGIN
Mauna Kea Technologies
Phase NA Completed
NCT00754468 2015-11-04
ESODOI
CSA Medical, Inc.
Phase 4 Completed
NCT01905202 2014-08-04
The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus
Effexus Pharmaceutical
Phase 1 Unknown
NCT00526786 2014-03-14
ICE
CSA Medical, Inc.
Phase 4 Terminated
NCT01209013 2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3 Withdrawn
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed
NCT00352261 2009-03-26
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
AstraZeneca
Phase 4 Completed